IMMUNE ESCAPE BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM NEUTRALIZING ANTIBODIES - EVIDENCE FOR MULTIPLE PATHWAYS

被引:53
作者
WATKINS, BA [1 ]
REITZ, MS [1 ]
WILSON, CA [1 ]
ALDRICH, K [1 ]
DAVIS, AE [1 ]
ROBERTGUROFF, M [1 ]
机构
[1] NCI,TUMOR CELL BIOL LAB,BETHESDA,MD 20892
关键词
D O I
10.1128/JVI.67.12.7493-7500.1993
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Sera from many HIV-1-infected individuals contain broadly reactive, specific neutralizing antibodies. Despite their broad reactivity, variant viruses, resistant to neutralization, can be selected in vitro in the presence of such antisera. We have previously shown that neutralization resistance of an escape mutant with an amino acid substitution in the transmembrane protein (A582T) occurs because of alteration or a conformational epitope that is recognized by neutralizing antibodies directed against the CD4 binding site. In this report we demonstrate that immune escape via a single-amino-acid substitution (A281V) within a conserved region of the envelope glycoprotein gp120 confers neutralization resistance against a broadly reactive neutralizing antiserum from a seropositive individual. We show this alteration affects V3 and additional regions unrelated to V3 or the CD4 binding site. Together with previous studies on escape mutants selected in vitro, our findings suggest that immune-selective pressure can arise by multiple pathways.
引用
收藏
页码:7493 / 7500
页数:8
相关论文
共 51 条
  • [21] CHARACTERIZATION OF HIV-1 NEUTRALIZATION ESCAPE MUTANTS
    MCKEATING, JA
    GOW, J
    GOUDSMIT, J
    PEARL, LH
    MULDER, C
    WEISS, RA
    [J]. AIDS, 1989, 3 (12) : 777 - 784
  • [22] MEYERS G, 1992, HUMAN RETROVIRUSES A
  • [23] NARA PL, 1990, VACCINES 90, P297
  • [24] ANTIGENIC DIVERSITY THRESHOLDS AND THE DEVELOPMENT OF AIDS
    NOWAK, MA
    ANDERSON, RM
    MCLEAN, AR
    WOLFS, TFW
    GOUDSMIT, J
    MAY, RM
    [J]. SCIENCE, 1991, 254 (5034) : 963 - 969
  • [25] CHARACTERIZATION OF A NEUTRALIZING MONOCLONAL-ANTIBODY TO THE EXTERNAL GLYCOPROTEIN OF HIV-1
    PAL, R
    VERONESE, FD
    NAIR, BC
    RAHMAN, R
    HOKE, G
    MUMBAUER, SW
    SARNGADHARAN, MG
    [J]. INTERVIROLOGY, 1992, 34 (02) : 86 - 93
  • [26] TYPE-SPECIFIC NEUTRALIZATION OF THE HUMAN IMMUNODEFICIENCY VIRUS WITH ANTIBODIES TO ENV-ENCODED SYNTHETIC PEPTIDES
    PALKER, TJ
    CLARK, ME
    LANGLOIS, AJ
    MATTHEWS, TJ
    WEINHOLD, KJ
    RANDALL, RR
    BOLOGNESI, DP
    HAYNES, BF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (06) : 1932 - 1936
  • [27] DETECTION, ISOLATION, AND CONTINUOUS PRODUCTION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND PRE-AIDS
    POPOVIC, M
    SARNGADHARAN, MG
    READ, E
    GALLO, RC
    [J]. SCIENCE, 1984, 224 (4648) : 497 - 500
  • [28] POSNER MR, 1991, J IMMUNOL, V146, P4325
  • [29] PROFY AT, 1990, J IMMUNOL, V144, P4641
  • [30] COMPLETE NUCLEOTIDE-SEQUENCE OF THE AIDS VIRUS, HTLV-III
    RATNER, L
    HASELTINE, W
    PATARCA, R
    LIVAK, KJ
    STARCICH, B
    JOSEPHS, SF
    DORAN, ER
    RAFALSKI, JA
    WHITEHORN, EA
    BAUMEISTER, K
    IVANOFF, L
    PETTEWAY, SR
    PEARSON, ML
    LAUTENBERGER, JA
    PAPAS, TS
    GHRAYEB, J
    CHANG, NT
    GALLO, RC
    WONGSTAAL, F
    [J]. NATURE, 1985, 313 (6000) : 277 - 284